Balloon angioplasty versus Viabahn stent graft for treatment of failing or thrombosed prosthetic hemodialysis grafts Thomas Vesely, MD, William DaVanzo,

Slides:

Advertisements

Similar presentations

Volume 69, Issue 5, Pages (March 2006)

Advertisements

Arterioarterial prosthetic loop: A new approach for hemodialysis access Juergen Zanow, MD, Ulf Kruger, MD, Michael Petzold, MD, Karen Petzold, MD, Helga.

Endovascular treatment of internal iliac artery obstructive disease

Comparison of covered stents versus bare metal stents for treatment of chronic atherosclerotic mesenteric arterial disease Gustavo S. Oderich, MD, Luke.

Freedom from secondary interventions to treat stenotic disease after percutaneous transluminal angioplasty of infrarenal aorta: long-term results J.P.P.M.

Karan Garg, MD, Caron B. Rockman, MD, Billy J. Kim, MD, Glenn R

Stenting of femoropopliteal lesions using interwoven nitinol stents

Linda Le, MD, William Terral, MD, Nicolas Zea, MD, Hernan A

Richard R. Proia, MD, Daniel B. Walsh, MD, Peter R. Nelson, MD, John P

Drug-Coated Balloon Angioplasty Confers No Advantage in the Treatment of Femoropopliteal Disease When Stenting Is Required Brian Tiu, MD, Michael Shih,

Ali F. AbuRahma, MD, J. David Hayes, MD, Sarah K

Ali F. AbuRahma, MD Journal of Vascular Surgery

Ung Bae Jeon, MD, Chang Won Kim, MD, Sung Woon Chung, MD

Results of the United States multicenter prospective study evaluating the Zenith fenestrated endovascular graft for treatment of juxtarenal abdominal.

Balloon angioplasty versus Viabahn stent graft for treatment of failing or thrombosed prosthetic hemodialysis grafts Thomas Vesely, MD, William DaVanzo,

Results of the randomized, placebo-controlled clopidogrel and acetylsalicylic acid in bypass surgery for peripheral arterial disease (CASPAR) trial Jill.

Tommaso Lupattelli, MD, Giovanni Nano, MD, Luigi Inglese, MD

Prosthetic lower extremity hemodialysis access grafts have satisfactory patency despite a high incidence of infection Irma L. Geenen, MD, Lydia Nyilas,

Blake A. Hamby, MD, Daniel E. Ramirez, MD, George E

Four-year randomized prospective comparison of percutaneous ePTFE/nitinol self- expanding stent graft versus prosthetic femoral-popliteal bypass in the.

Vascular interventions in head and neck cancer patients as a marker of poor survival Emilia Krol, MD, Colin T. Brandt, MD, Juliet Blakeslee-Carter, BS,

Kevin J. Bruen, MD, Robert J. Feezor, MD, Michael J

Percutaneous transluminal angioplasty for the treatment of limb threatening ischemia: Do the results justify an attempt before bypass grafting? Richard.

William C. Jennings, MD, Matthew J. Sideman, MD, Kevin E

Late outcomes of balloon angioplasty and angioplasty with selective stenting for superficial femoral-popliteal disease are equivalent Bao-Ngoc Nguyen,

Factors related to outcome of neuroischemic/ischemic foot ulcer in diabetic patients Jan Apelqvist, MD, PhD, Targ Elgzyri, MD, Jan Larsson, MD, PhD, Magnus.

Treatment of limb-threatening ischemia with percutaneous intentional extraluminal recanalization: a preliminary evaluation Gerald S Treiman, MD, John.

Percutaneous transluminal angioplasty versus primary stenting in infrapopliteal arterial disease: A meta-analysis of randomized trials Ridong Wu, MD,

A comparison of patency and interventions in thigh versus Hemodialysis Reliable Outflow grafts for chronic hemodialysis vascular access Evan R. Brownie,

Surgical revascularization versus endovascular therapy for chronic mesenteric ischemia: A comparative experience Marvin D. Atkins, MD, Christopher J.

Cryopreserved saphenous vein graft in infrainguinal bypass

Randomized comparison of ePTFE/nitinol self-expanding stent graft vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery.

Open versus endovascular revascularization for chronic mesenteric ischemia: Risk- stratified outcomes Gustavo S. Oderich, MD, Thomas C. Bower, MD, Timothy.

Chetan P. Huded, MD, Philip P. Goodney, MD, Richard J

Marc L. Schermerhorn, MD, Kristina A. Giles, MD, Allen D

Outcomes of reoperative open or endovascular interventions to treat patients with failing open mesenteric reconstructions for mesenteric ischemia Karina.

Reduced primary patency rate in diabetic patients after percutaneous intervention results from more frequent presentation with limb-threatening ischemia

Safety and efficacy of antiplatelet/anticoagulation regimens after Viabahn stent graft treatment for femoropopliteal occlusive disease Brant W. Ullery,

Sadaf S. Ahanchi, MD, Christopher L. Stout, MD, Tyler J

Stent placement for treatment of central and peripheral venous obstruction: A long-term multi-institutional experience Gustavo S.C. Oderich, MD, Gerald.

Long-term outcomes of primary angioplasty and primary stenting of central venous stenosis in hemodialysis patients Andrew M. Bakken, MD, Clinton D. Protack,

Atherectomy offers no benefits over balloon angioplasty in tibial interventions for critical limb ischemia Kevin E. Todd, BS, Sadaf S. Ahanchi, MD, Christian.

Nitinol stenting improves primary patency of the superficial femoral artery after percutaneous transluminal angioplasty in hemodialysis patients: A propensity-matched.

Ten-year experience with renal artery in-stent stenosis

Balloon angioplasty for revision of failing lower extremity bypass grafts Haitham Ali, MD, Ahmed Elbadawy, MD, Mahmoud Saleh, MD, Ayman Hasaballah, MD

Toshifumi Kudo, MD, PhD, Fiona A. Chandra, Samuel S. Ahn, MD

Balloon angioplasty vs nitinol stent placement in the treatment of venous anastomotic stenoses of hemodialysis grafts after surgical thrombectomy John.

Chung-Dann Kan, MD, Hsin-Ling Lee, MD, Yu-Jen Yang, MD, PhD

David H. Stone, MD, David C. Brewster, MD, Christopher J

Paclitaxel-coated versus plain balloon angioplasty in the treatment of infrainguinal vein bypass stenosis Klaus Linni, MD, Ara Ugurluoglu, MD, Manuela.

Use of the Viabahn stent graft for the treatment of recurrent cephalic arch stenosis in hemodialysis accesses Gregg A. Miller, MD, Dean C. Preddie, MD,

Durability of percutaneous transluminal angioplasty for obstructive lesions of proximal subclavian artery: Long-term results Jean-Paul P.M. de Vries,

Manish Mehta, MD, MPH, Yi Zhou, MD, Philip S. K

Infrainguinal arterial reconstructions in patients with aortoiliac occlusive disease: The influence of iliac stenting Carlos H. Timaran, MD, Scott L.

A personal experience with factors influencing survival after elective open repair of infrarenal aortic aneurysms Norman R. Hertzer, MD, Edward J. Mascha,

Optimizing infrainguinal arm vein bypass patency with duplex ultrasound surveillance and endovascular therapy Paul A. Armstrong, DO, Dennis F. Bandyk,

A comparison of the standard bolia technique versus subintimal recanalization plus Viabahn stent graft in the management of femoro-popliteal occlusions

M. Chris Pastor, MD, MSc, David Kopriva, MDCM, FRCS(C)

Christopher J. Abularrage, MD, Mark F. Conrad, MD, MMSc, Lauren A

High incidence of restenosis/reocclusion of stents in the percutaneous treatment of long-segment superficial femoral artery disease after suboptimal angioplasty

Efficacious use of nitinol stents in the femoral and popliteal arteries Todd R Vogel, MD, Larry E Shindelman, MD, Gary B Nackman, MD, Alan M Graham, MD

Differences in anatomy and outcomes in patients treated with open mesenteric revascularization before and after the endovascular era Evan J. Ryer, MD,

The effectiveness of percutaneous transluminal angioplasty for the treatment of critical limb ischemia: A 10-year experience Toshifumi Kudo, MD, PhD,

Results of second-time angioplasty and stenting for femoropopliteal occlusive disease and factors affecting outcomes William P. Robinson, MD, Louis L.

John L. Anderson, Donald J. Adam, MD, Michael Berce, David E. Hartley

Midterm outcomes of the Zenith Renu AAA Ancillary Graft

Percutaneous transluminal angioplasty and stenting as first-choice treatment in patients with chronic mesenteric ischemia Bram Fioole, MD, PhD, Hendrik.

Everolimus Drug-Eluting Stents Are Associated With Improved Outcomes for the Treatment of Infrainguinal Bypass Graft Stenoses Caitlin W. Hicks, MD, MS,

Iliac artery stenting versus surgical reconstruction for TASC (transatlantic inter-society consensus) type B and type C iliac lesions Carlos H Timaran,

Scott M. Surowiec, MD, Mark G. Davies, MD, PhD, Shirley W

Presentation transcript:

Balloon angioplasty versus Viabahn stent graft for treatment of failing or thrombosed prosthetic hemodialysis grafts Thomas Vesely, MD, William DaVanzo, MD, Terry Behrend, MD, Amy Dwyer, MD, John Aruny, MD Journal of Vascular Surgery Volume 64, Issue 5, Pages 1400-1410.e1 (November 2016) DOI: 10.1016/j.jvs.2016.04.035 Copyright © 2016 The Authors Terms and Conditions

Fig 1 Distribution of patients. Journal of Vascular Surgery 2016 64, 1400-1410.e1DOI: (10.1016/j.jvs.2016.04.035) Copyright © 2016 The Authors Terms and Conditions

Fig 2 Stent grafts improve primary patency of target lesion and access circuit compared with balloon angioplasty. Kaplan-Meier estimates of primary patency of the target lesion (A) and access circuit (B). In all cases, stent grafts demonstrated statistical superiority in patency compared with balloon angioplasty. (P values shown in each panel were calculated using the log-rank test). EPP, Effectiveness-per-protocol; ITT, intention to treat; PTA, percutaneous transluminal angioplasty. Journal of Vascular Surgery 2016 64, 1400-1410.e1DOI: (10.1016/j.jvs.2016.04.035) Copyright © 2016 The Authors Terms and Conditions